Literature DB >> 3282146

Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension.

C E Mondon1, G M Reaven.   

Abstract

Various aspects of insulin metabolism were compared in rats with spontaneous hypertension (SHR) and a suitable control group of similar sized Kyota Wistar (WKY) rats. The results indicated that the total integrated serum insulin response to an oral glucose challenge was significantly greater in the SHR rats, despite the fact that the total integrated serum glucose responses were similar in the two groups. This indirect evidence of resistance to insulin-stimulated glucose disposal was supported by the observation that the ability of similar serum concentrations of exogenous insulin to stimulate glucose disposal was reduced in SHR rats. In addition, the metabolic clearance rate of insulin was lower in the SHR rats. These data indicate that abnormalities in insulin secretion, action, and catabolism exist in rats with spontaneous hypertension. Whether this defect is unique to SHR rats, or common to all forms of experimental hypertension, is an important issue. Equally important is the relationship between the observed changes in insulin metabolism and the elevated blood pressure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3282146     DOI: 10.1016/0026-0495(88)90127-8

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  18 in total

1.  Insulin signalling pathways in aorta and muscle from two animal models of insulin resistance--the obese middle-aged and the spontaneously hypertensive rats.

Authors:  H G Zecchin; R M N Bezerra; J B C Carvalheira; M A Carvalho-Filho; K Metze; K G Franchini; M J A Saad
Journal:  Diabetologia       Date:  2003-04-05       Impact factor: 10.122

Review 2.  Insulin resistance and hypertension.

Authors:  M Lachaal; C Y Jung
Journal:  Mol Cell Biochem       Date:  1992-02-12       Impact factor: 3.396

Review 3.  Insulin receptor/IRS-1/PI 3-kinase signaling system in corticosteroid-induced insulin resistance.

Authors:  F Folli; M J Saad; C R Kahn
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

Review 4.  Antihypertensive effects of vanadium compounds in hyperinsulinemic, hypertensive rats.

Authors:  S Bhanot; A Michoulas; J H McNeill
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

5.  The novel ATP-sensitive potassium channel opener iptakalim prevents insulin resistance associated with hypertension via restoring endothelial function.

Authors:  Yu Wang; Fu-hu Zeng; Chao-liang Long; Zhi-yuan Pan; Wen-yu Cui; Ru-huan Wang; Guo-shu Liu; Hai Wang
Journal:  Acta Pharmacol Sin       Date:  2011-11-07       Impact factor: 6.150

6.  Dietary lipoic acid supplementation attenuates hypertension in Dahl salt sensitive rats.

Authors:  Sudesh Vasdev; Vicki Gill; Sushil Parai; Veeresh Gadag
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

7.  Salt-induced hypertension in WKY rats: prevention by alpha-lipoic acid supplementation.

Authors:  Sudesh Vasdev; Vicki Gill; Linda Longerich; Sushil Parai; Veeresh Gadag
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

Review 8.  The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension.

Authors:  Linda T Tran; Violet G Yuen; John H McNeill
Journal:  Mol Cell Biochem       Date:  2009-06-18       Impact factor: 3.396

9.  A low-carbohydrate/high-fat diet reduces blood pressure in spontaneously hypertensive rats without deleterious changes in insulin resistance.

Authors:  John D Bosse; Han Yi Lin; Crystal Sloan; Quan-Jiang Zhang; E Dale Abel; Troy J Pereira; Vernon W Dolinsky; J David Symons; Thunder Jalili
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-19       Impact factor: 4.733

10.  Mechanism of compensatory hyperinsulinemia in normoglycemic insulin-resistant spontaneously hypertensive rats. Augmented enzymatic activity of glucokinase in beta-cells.

Authors:  C Chen; H Hosokawa; L M Bumbalo; J L Leahy
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.